Clinical approach to the critically ill, morbidly obese patient.
El-Solh
Ali A
AA
Department of Medicine, University at Buffalo School of Medicine and Biomedical Sciences, New York, USA. solh@buffalo.edu
D000698:Analgesia / Q000379:methods; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001835:Body Weight; D002405:Catheterization, Central Venous / Q000379:methods; D003422:Critical Care / Q000379:methods*; D016638:Critical Illness; D015391:Gastroplasty; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use; D009751:Nutritional Requirements; D009767:Obesity, Morbid / Q000453:epidemiology / Q000628:therapy*; D010360:Patient Transfer; D019990:Perioperative Care / Q000379:methods; D014481:United States / Q000453:epidemiology; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D006993:Hypnotics and Sedatives; D009466:Neuromuscular Blocking Agents